Exos Asset Management’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$736K Sell
75,929
-1,022
-1% -$9.9K 0.38% 85
2022
Q1
$748K Buy
76,951
+3,402
+5% +$32.9K 0.32% 98
2021
Q4
$722K Buy
+73,549
New +$721K 0.37% 91

Other funds holding DALS

Exos Asset Management's DALS Position: Q2 2022 in Review

Exos Asset Management reduced its DA32 Life Science Tech Acquisition Corp (DALS) stake by 1.3% in Q2 2022, selling an estimated $9.9K and leaving 75,929 shares worth $736K. The position accounts for 0.38% of the portfolio, ranked #85.

Exos Asset Management first reported a position in DALS in Q4 2021 and has held it in 3 quarters since. The position peaked at $748K in Q1 2022. 45 funds tracked by Wall St. Rank hold DALS as of Q2 2022.

  • Exos Asset Management held 75,929 shares of DA32 Life Science Tech Acquisition Corp worth $736K as of Q2 2022.
  • Exos Asset Management sold 1,022 DA32 Life Science Tech Acquisition Corp shares in Q2 2022, an estimated $9.9K.
  • DA32 Life Science Tech Acquisition Corp made up 0.38% of Exos Asset Management's portfolio in Q2 2022, its #85 holding.
  • Exos Asset Management first reported a position in DA32 Life Science Tech Acquisition Corp in Q4 2021 and has held it in 3 quarters since.
  • Exos Asset Management's DA32 Life Science Tech Acquisition Corp position peaked at $748K in Q1 2022.
  • 45 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q2 2022.

Based on Exos Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.